(Q24234207)

2

object named as

Jan E Clarkson

0 references

author name string

Tasneem Khalid

3

0 references

Stefan Meyer

4

0 references

Martin McCabe

Cochrane Database of Systematic Reviews

5

0 references

publication date

7 July 2010

0 references

published in

0 references

cites work

Comparison of the efficacy and safety of miconazole 50-mg mucoadhesive buccal tablets with miconazole 500-mg gel in the treatment of oropharyngeal candidiasis: a prospective, randomized, single-blind, multicenter, comparative, phase III trial in pat

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001972.PUB4

A comparative study of the efficacy of fluconazole and amphotericin B in the treatment of oropharyngeal candidosis in patients undergoing radiotherapy for head and neck tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001972.PUB4

An open multicentre comparative study of the efficacy, safety and tolerance of fluconazole and itraconazole in the treatment of cancer patients with oropharyngeal candidiasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001972.PUB4

Management of invasive candidal infections: results of a prospective, randomized, multicenter study of fluconazole versus amphotericin B and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001972.PUB4

Comparison of amphotericin B lipid complex (ABLC) vs. ambisome in the treatment of suspected or documented fungal infections in patients with leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001972.PUB4

Flaws in design, analysis and interpretation of Pfizer's antifungal trials of voriconazole and uncritical subsequent quotations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001972.PUB4

A comparative study of the efficacy and safety of fluconazole oral suspension and amphotericin B oral suspension in cancer patients with mucositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001972.PUB4

Low-dose amphotericin B lipid complex vs. conventional amphotericin B for empirical antifungal therapy of neutropenic fever in patients with hematologic malignancies--a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001972.PUB4

Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001972.PUB4

Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001972.PUB4

Routine versus selective antifungal administration for control of fungal infections in patients with cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001972.PUB4

Interventions for treating oral candidiasis for patients with cancer receiving treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001972.PUB4

Amphotericin B versus amphotericin B plus 5-flucytosine: Poor results in the treatment of proven systemic mycoses in neutropenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001972.PUB4

Does ketoconazole prevent fungal infection in children treated with high dose chemotherapy and bone marrow transplantation? Results of a randomized placebo-controlled trial

21 January 2018

1 reference

12 December 2020

Prophylactic and therapeutic effects of oral administration of amphotericin B in mycosis associated with hematologic diseases. Study Group of Mycosis in Hematologic Disease

1 reference

12 December 2020

Interventions for treating oral mucositis for patients with cancer receiving treatment

1 reference

12 December 2020

Therapy for oropharyngeal candidiasis in the immunocompromised host: a randomized double-blind study of fluconazole vs. ketoconazole.

1 reference

12 December 2020

Interventions for preventing oral candidiasis for patients with cancer receiving treatment

1 reference

12 December 2020

Interventions for preventing oral mucositis for patients with cancer receiving treatment

1 reference

12 December 2020

Ketoconazole and Candidiasis: A Controlled Study

1 reference

12 December 2020

Oropharyngeal Candidiasis Treated With a Troche Form of Clotrimazole

1 reference

12 December 2020

Oropharyngeal candidiasis in immunocompromised children: a randomized, multicenter study of orally administered fluconazole suspension versus nystatin. The Multicenter Fluconazole Study Group

1 reference

12 December 2020

Fluconazole versus amphotericin B in the treatment of esophageal candidiasis in cancer patients

1 reference

12 December 2020

Fluconazole versus itraconazole in therapy of oropharyngeal candidiasis in cancer patients: a prospective comparative randomized trial

1 reference

12 December 2020

Clotrimazole treatment of oral candidiasis in patients with neoplastic disease

1 reference

12 December 2020

Natamycin and nystatin for treatment of oral candidiasis during and after radiotherapy

1 reference

12 December 2020